Skip to main content
. Author manuscript; available in PMC: 2013 May 15.
Published in final edited form as: Circulation. 2012 Mar 25;125(19):2353–2362. doi: 10.1161/CIRCULATIONAHA.111.081125

Figure 3.

Figure 3

Effect of sildenafil on passive (mPAP ≥25 and PVR <3) (a) and reactive (mPAP ≥25 and PVR ≥3) (b) pulmonary venous hypertension. Median % change reported. *Based on Wilcoxon signed-ranks test of the percent change from baseline to 60 minutes; indicates significance at p<0.05. Abbreviations as in Table 2.